Chemplast Sanmar Ltd Q4 FY26 Earnings Analysis

- R32 Plant: Targeting 14,000 tons capacity with phased commissioning; first full year revenue expected around INR 550 crores from ~11,000 tons production. - Custom Manufacturing Chemicals Division (CMCD): INR 1,000 crores revenue target by FY 2027-28, though delayed by 2-3 quarters due to ramp-up and market factors. - Suspension PVC: Demand expected to recover strongly in H2 FY 2026 after a flat first 9 months; breakeven expected by Feb-Mar at PBT level. - Paste PVC: Strong demand growth (~8% increase Y-o-Y in first 9 months) with recent price hikes; further margin improvements anticipated. - Overall: Company expects sustainable growth ahead driven by improving PVC market sentiment, ramp-up in specialty chemicals, and expansions, with no large capex planned beyond current projects.

- The company is optimistic about sustainable growth ahead, supported by improving market sentiment, particularly in Suspension PVC. - The Custom Manufactured Chemicals Division (CMCD) aims for INR 1,000 crores revenue by FY '28, despite a delay of 2-3 quarters; margins expected steady at 20-25% in steady state. - R32 production capacity is expected to scale to 14,000 tons by end of calendar year, targeting INR 550 crore revenue in the first full year with a short-term breakeven horizon. - Suspension PVC has reached breakeven at PBT level by Feb-Mar ’26; further price hikes can improve profitability. - Earnings improvement influenced positively by rationalization of PVC capacity in China due to withdrawal of export rebate from April 2026. - No specific margin or EPS guidance given; company prefers not to provide numeric forecasts yet. - Management change effective April 2026 expected to continue building on strong foundation.

- Current and future capex primarily includes the commissioning and expansion of the R32 plant and residual capex related to CMC (Custom Manufactured Chemicals) expansions. - The R32 plant expansion involves: - Swing plant of 2,000 tons operational by end of current quarter. - Additional 2,000-ton plant by Q1 next year. - Last 10,000-ton plant by end of calendar year. - No large capex planned beyond these; the rest is mainly maintenance capex. - Details on maintenance capex and segment-wise capex can be provided offline. - New product development and CMC capex are on time despite some short-term agchem market slowdowns. - No current plans for equity fundraising; any future fundraising (equity or debt) will proceed as per project and operational requirements.

- Fundraising is an ongoing exercise to support projects and short-term requirements. - Currently, there are no plans for any equity raising. - No specific comment was made regarding fundraising plans beyond the next 2 years. - The company manages fundraising as per its ongoing requirements and plans.

The transcript provided does not explicitly mention the current or expected order book or pending orders for Chemplast Sanmar Limited. However, some related insights include: - Custom Manufactured Chemicals (CMC) business: The pipeline remains strong with ongoing customer engagements and new product developments, though there is a delay in ramp-up due to agrochemical industry slowdown. Management remains confident of reaching INR 1,000 crores target by FY '27-'28. - For the R32 plant, commercial sales are expected to start post commissioning by end of the current quarter, with initial capacity largely targeted at the domestic market and export mix expected with full capacity. - No explicit mention of exact order book or pending orders figures in the call transcript. For detailed order book or pending order data, contacting the company or Investor Relations directly is recommended.